Palvella Therapeutics
PVLA
142.85
-2.92
-2.00%
Palvella Therapeutics
US · PVLA
#2822 by market cap
Listed 1970
142.85
-2.92
-2.00%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 12 analysts
Buy
Avg price target 227.73 +59.4%
Price target rangecurrent 142.85
Low207.00
Avg227.73
High246.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-09 | CCORF | -- | Buy | 243.00 |
| 2026-11-06 | Craig-Hallum | -- | Buy | 230.00 |
| 2026-11-06 | Raymond James | -- | Buy | 230.00 |
| 2026-11-06 | Truist Financial | -- | Buy | 207.00 |
| 2026-11-06 | H.C. Wainwright | -- | Buy | 246.00 |
| 2026-11-06 | Oppenheimer | -- | Buy | 232.00 |
| 2026-11-05 | BTIG | -- | Buy | 215.00 |
| 2026-10-29 | Mizuho Securities | -- | Buy | 232.00 |
| 2026-10-28 | William Blair | -- | Buy | -- |
| 2026-10-21 | Cantor Fitzgerald | -- | Buy | 210.00 |
| 2026-10-20 | Clear Street | -- | Buy | 220.00 |
| 2026-10-20 | H.C. Wainwright | -- | Buy | 246.00 |
| 2026-10-16 | Raymond James | -- | Buy | -- |
| 2026-10-15 | William Blair | -- | Buy | 266.00 |
| 2026-10-12 | BTIG | -- | Buy | 215.00 |
| 2026-10-12 | H.C. Wainwright | -- | Buy | 246.00 |
| 2026-09-21 | Chardan Capital | -- | Buy | 240.00 |
| 2026-09-10 | Mizuho Securities | -- | Buy | 240.00 |
| 2026-08-31 | Mizuho Securities | -- | Buy | 240.00 |
| 2026-08-05 | CCORF | -- | Buy | 232.00 |
| 2026-08-05 | LifeSci Capital | -- | Buy | 236.00 |
| 2026-08-05 | Truist Financial | -- | Buy | 207.00 |
| 2026-08-05 | H.C. Wainwright | -- | Buy | 270.00 |
| 2026-08-05 | Oppenheimer | -- | Buy | 210.00 |
| 2026-08-04 | TD Cowen | -- | Buy | 267.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | -- | ±8.76% | -3.35% (in line) |
| 2026/Q2 | 2026-08-04 | -- | ±11.09% | +7.96% (in line) |
| 2026/Q1 | 2026-05-07 | -- | ±8.37% | -12.99% (beat) |
| 2025/Q4 | 2026-03-31 | -- | ±12.16% | +12.64% (beat) |
| 2025/Q3 | 2025-11-11 | -- | ±9.99% | -3.04% (in line) |
| 2025/Q2 | 2025-08-14 | -- | -- | +3.27% |
| 2025/Q1 | 2025-05-15 | -- | -- | -0.41% |
| 2024/Q4 | 2025-03-31 | -- | -- | -0.39% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Palvella Therapeutics discussion 0 comments